Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $138.14 +1.67%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q2 EPS of $1.00, $0.01 better than the analyst estimate of $0.99. Revenue for the quarter came in at $2.14 billion versus the consensus estimate of $2.07 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Innovaro (INV) Misses Q2 EPS by 9c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
